Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochemistry

• Publication date

  1994-12-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00252A007PMID 7981201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.

  1994cited by this paper
• Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B.

  1994cited by this paper
• Human progelatinase A can be activated by matrilysin

  1994cited by this paper
• Quantitative zymography: detection of picogram quantities of gelatinases.

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.

  1994cited by this paper
• Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

  1993cited by this paper
• Direct activation of human neutrophil procollagenase by recombinant stromelysin.

  1993cited by this paper
• Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain.

  1993cited by this paper
• Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.

  1993cited by this paper
• The role of the C-terminal domain in collagenase and stromelysin specificity.

  1992cited by this paper
• EXAFS Evidence for a "Cysteine Switch" in the Activation of Prostromelysin

  1992cited by this paper
• A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases

  1992cited by this paper
• Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases.

  1992cited by this paper
• The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

  1992cited by this paper
• Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

  1992cited by this paper
• Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

  1992cited by this paper
• Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.

  1991cited by this paper
• The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.

  1991cited by this paper
• Sequence specificities of human fibroblast and neutrophil collagenases.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.

  1991cited by this paper
• Substrate specificities and activation mechanisms of matrix metalloproteinases.

  1991cited by this paper
• Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

  1991cited by this paper
• Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.

  1990cited by this paper
• The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

  1990cited by this paper
• Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).

  1990cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

  1990cited by this paper
• Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.

  1990cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G

  1989cited by this paper
• The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

  1989cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products.

  1987cited by this paper
• Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

  1987cited by this paper
• Comparison of human stromelysin and collagenase by cloning and sequence analysis.

  1986cited by this paper
• Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma.

  1986cited by this paper
• Histopathology of the rheumatoid lesion

  1984cited by this paper
• Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion.

  1984cited by this paper
• Kinetics of activation and autoactivation of human factor XII.

  1984cited by this paper

• Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease

  2023cites this paper
• Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma

  2021cites this paper
• Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer

  2021cites this paper
• The Good and Bad Sides of Heparanase-1 and Heparanase-2.

  2020cites this paper
• Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition 1.

  2019cites this paper
• CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9

  2018cites this paper
• Peripheral membrane associations of matrix metalloproteinases.

  2017cites this paper
• Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo

  2015cites this paper
• Extracellular regulation of metalloproteinases.

  2015cites this paper
• Extracellular regulation of Kazuhiro Yama

  2015cites this paper
• Myocardial matrix metalloproteinase-2: inside out and upside down.

  2014cites this paper
• Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.

  2013cites this paper
• Chapter 78 – Catalytic Mechanisms for Metallopeptidases

  2013cites this paper
• Functional interactions between matrix metalloproteinases and glycosaminoglycans

  2013cites this paper
• Design, synthesis and biological evaluation of ferulic Acid amides as selective matrix metalloproteinase inhibitors.

  2013cites this paper
• Green tea inhibits proteolytic enzymes in GCF from patients with chronic periodontitis

  2012cites this paper
• Design, Synthesis and Biological Evaluation of Caffeic Acid Amides as Selective MMP‐2 and MMP‐9 Inhibitors

  2012cites this paper
• Design, Synthesis, and Preliminary Evaluation of Substituted Cinnamic Acid Esters as Selective Matrix Metalloproteinase Inhibitors

  2012cites this paper
• Cellular microenvironment in Burkitt’s lymphoma : gene expression profiling of tumour-associated macrophages in situ

  2012cites this paper
• Structural Basis of Extracellular Matrix Interactions with Matrix Metalloproteinases

  2011cites this paper
• Regulation of matrix metalloproteinase activity in health and disease

  2011cites this paper
• Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.

  2010cites this paper
• GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.

  2010cites this paper
• Effect of Methamphetamine on Gingival Fibroblast Production of Matrix Metalloproteinase (MMP)-2 and -9 and Tissue Inhibitor of Metalloproteinase (TIMP)-1 and -2 In Vitro

  2009cites this paper
• Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation

  2009cites this paper
• Control of Promatrilysin (MMP7) Activation and Substrate-specific Activity by Sulfated Glycosaminoglycans*

  2009cites this paper
• Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis

  2008cites this paper
• Conjugated linoleic acid alters matrix metalloproteinases of metastatic mouse mammary tumor cells.

  2007cites this paper
• Conjugated Linoleic Acid Alters Matrix Metalloproteinases of Metastatic Mouse Mammary Tumor Cells 1 , 2

  2007cites this paper
• Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-&bgr;

  2007cites this paper
• Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts.

  2007cites this paper
• Mast cell-dependent activation of pro matrix metalloprotease 2: a role for serglycin proteoglycan-dependent mast cell proteases

  2006cites this paper
• Metalloproteinases and human placental invasiveness.

  2006cites this paper
• Temporal expression of protein mediators during PGF2alpha-induced luteolysis in sheep

  2006cites this paper
• A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*

  2005cites this paper
• Gelatinase-mediated migration and invasion of cancer cells.

  2005cites this paper
• Furin Directly Cleaves proMMP-2 in the trans-Golgi Network Resulting in a Nonfunctioning Proteinase*

  2005cites this paper
• Pancreatic trypsin activates human promatrix metalloproteinase-2.

  2005cites this paper
• X-ray Structure of Human proMMP-1

  2005cites this paper
• Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts.

  2004cites this paper
• Catalytic mechanisms for metallopeptidases

  2004cites this paper
• The pathobiology of aortic aneurysms.

  2004cites this paper
• New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).

  2004cites this paper
• MATRIX METALLOPROTEINASE-2 (MMP-2) AND -9 (MMP-9) IN HEMATOLOGICAL MALIGNANCIES

  2003cites this paper
• Connective Tissue Formation in Wound Healing An experimental study

  2003cites this paper
• Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.

  2003cites this paper
• Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.

  2002cites this paper
• Thermolysin activates equine lamellar hoof matrix metalloproteinases.

  2002cites this paper
• Membrane-type-1 matrix metalloproteinase in pericellular proteolysis and cell migration

  2002cites this paper
• Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion

  2002cites this paper
• The Role of Matrix Metalloproteinase Genes in Glioma Invasion: Co-dependent and Interactive Proteolysis

  2001cites this paper
• Human endothelial gelatinases and angiogenesis.

  2001cites this paper
• The expression and localization of membrane type-1 matrix metalloproteinase in human abdominal aortic aneurysms.

  2001cites this paper
• Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis

  2000cites this paper
• Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP.

  2000cites this paper
• Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7)*

  2000cites this paper
• Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.

  2000cites this paper
• Metalloproteinase-2 Activation Its Potential Involvement in ( Matrilysin ) by Human Myeloma Cells and Production of Metalloproteinase-7

  1999cites this paper
• Pentosan Polysulfate Decreases Proliferation and Net Extracellular Matrix Production in Mouse Mesangial Cells

  1999cites this paper
• Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells.

  1999cites this paper
• Pentosan polysulfate decreases proliferation and net extracellular matrix production in mouse mesangial cells.

  1999cites this paper
• 92K-GL (MMP-9) and 72K-GL (MMP-2) are Produced in vivo by Human Oral Squamous Cell Carcinomas and can Enhance FIB-CL (MMP-1) Activity in vitro

  1999cites this paper
• Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis.

  1999cites this paper
• Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.

  1999cites this paper
• Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases.

  1999cites this paper
• Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.

  1999cites this paper
• Matrix metalloproteinase secretion is stimulated by TGF-beta in cultured lens epithelial cells.

  1999cites this paper
• Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms.

  1998cites this paper
• Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation

  1998cites this paper
• Effect of pH on proteinase secretion by transformed fibroblast populations.

  1998cites this paper
• Production of trypsins by human gastric cancer cells correlates with their malignant phenotype.

  1998cites this paper
• Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development.

  1998cites this paper
• Expression of Human Pro-Matrix Metalloproteinase 3 that Lacks the N-terminal 34 Residues in Escherichia coli: Autoactivation and Interaction with Tissue Inhibitor of Metalloproteinase 1 (TIMP-1)

  1998cites this paper
• Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.

  1998cites this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cites this paper
• Activation of MMP‐2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent

  1998cites this paper
• Design and Use of Synthetic Peptides as Biological Models

  1998cites this paper
• [Matrix metalloproteinases and their biological functions].

  1998cites this paper
• CYTOKINE INDUCIBLE MATRIX METALLOPROTEINASE EXPRESSION IN

  1998cites this paper
• Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.

  1998cites this paper
• Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor

  1997cites this paper
• Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases.

  1997cites this paper
• Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.

  1997cites this paper
• Activation mechanisms of matrix metalloproteinases.

  1997cites this paper
• Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.

  1997cites this paper
• Activation of human progelatinase A by collagenase and matrilysin: Activation of procollagenase by matrilysin

  1996cites this paper
• Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides.

  1996cites this paper
• Matrix metalloproteinases and their tissue inhibitors in endometrial remodelling and menstruation

  1996cites this paper
• Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury

  1996cites this paper
• Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.

  1996cites this paper
• Computational sequence analysis of matrix metalloproteinases

  1996cites this paper
• Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew.

  1996cites this paper
• Metalloproteinase inhibitors and the prevention of connective tissue breakdown.

  1996cites this paper
• Expression, activation, and processing of the recombinant snake venom metalloproteinase, pro-atrolysin E.

  1996cites this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cites this paper
• An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A

  1996cites this paper
• Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP)

  1996cites this paper
• IDENTIFICATION OF TWO MATRIX METALLOPROTEINASES IN THE SKELETAL MUSCLE OF PACIFIC ROCKFISH (SEBASTES SP.)

  1995cites this paper
• Characterization of Rat Uterine Matrilysin and Its cDNA

  1995cites this paper
• Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts.

  1995cites this paper